Boryung Records 535 Billion Won in First-Half Sales...Taxotel Revenues Begin in Earnest
Operating Profit Reaches 44 Billion Won, Setting a Record for Highest-Ever Half-Year Performance
"Internal Growth Drivers Become Evident in Financial Results"
Boryung (Boryung Pharmaceutical) announced on August 6, 2026, that it achieved the highest-ever half-year sales and operating profit on a consolidated basis, recording sales of 535 billion won and operating profit of 44 billion won for the first half of the year. These figures reflect increases of 8.7% and 21.1%, respectively, compared to the same period last year.
The second quarter results were bolstered by newly generated global business revenues. 'Taxotel' (ingredient name: docetaxel), a cytotoxic anticancer drug acquired by Boryung from Sanofi last year, began generating global sales in earnest starting in June. Boryung has secured all global business rights for Taxotel, including rights for distribution, approval, production, and trademarks, both in Korea and worldwide.
Additionally, the supply of cytotoxic anticancer drug CDMO (Contract Development and Manufacturing Organization) services, with the Yesan campus as a base, commenced in the first half, diversifying Boryung's revenue structure. Based on this foundation, Boryung is expanding from a domestic, prescription-centered structure to a global pharmaceutical market strategy. The company is transitioning acquired brands into its own production systems, then leveraging its manufacturing capabilities to connect back into CDMO operations.
The results also reflect the successful launch of new products. 'Kanarbjet', an antihypertensive and dyslipidemia treatment released in May, sold out its initial batch, totaling 3.7 billion won, within the first half of the year.
Hot Picks Today
"Ruined Because of Korea" Even with a Sharp Rally, No One Buys... Japanese Market Sways with KOSPI
- '1,670,000 Won to 1,170,000 Won': SK hynix Hits Lower Limit Shock, Pre-market Opening Price Controversy
- "Second-Phase Public Institution Relocation Is Crucial for TK's Survival"... Unified Voices at Regional Era Forum
- "Don't Be Sad, Mom Was Very Happy"... Son Battling Illness for Life Saves Four Before Passing Away
- "Don't Worry, That's Just How It Is"... Thai Tourists in Korea Touched by Elderly Man Who Paid for Their Meal
A company representative said, "Following the acquisition of Taxotel, we began to record global sales. The simultaneous expansion of CDMO supply and the launch of new products during the same period have started to manifest as internal growth drivers. The results verify the success of our business structure transformation and demonstrate the structural stability of our portfolio."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
